TrialClinical cancer research : an official journal of the American Association for Cancer Research2010

CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.

Mark E Dudley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.